We are proud to present our 8th annual
Biosimilars and Biobetters conference which returns to London in September 2017 to reflect on the ongoing issues and latest developments in this rapidly expanding field.
As the patents for several innovator biologics expire, biopharmaceutical companies are taking the opportunity to develop more affordable forms. By the year 2018 more than 30 innovator biologics with sales of $79 billion will have lost their patents making
biosimilars one of the fastest growing markets. This year's event will bring together industry leaders to discuss the latest cases and complexities in the commercialisation and design of
biosimilars. We will explore regulatory guidelines and the ways in which interchangeability is likely to shape the market. We will identify challenges to manufacturing, deepen our understanding of clinical trial design, and discuss the topic of pricing.
As the field of
biosimilars evolves, challenges in immunogenicity studies and exclusivity still persist. Join us as we address the many pressing issues in this exciting field and hear from regulatory bodies how best to secure approval.
Benefits of Attending
- Understand and address the regulatory challenges facing biosimilars including the latest interchangeability guidelines
- Hear about the latest innovative strategies to clinical trial design
- Gain insight into market access and optimal pricing for new biosimilars
- Case studies on biosimilars and innovator products on the market
- Discuss challenges and potential solutions to in IP laws, exclusivity and HCP acceptance
- Develop deeper understanding of the ongoing problems still facing biosimilar drug development
Plus Two Interactive Half-Day Pre-Conference Workshops | Tuesday 26th September 2017
Workshop A: Establishing winning commercial strategies in markets where biosimilars are entering
Workshop Leader: Christopher Teale, Senior Vice President Market Access, GfK
08.30 - 12.30
Workshop B: New regulations affecting biosimilars in the USA and Europe and its impact on biosimilar adoption
Workshop Leaders: Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals
Michel Mikhail, Senior VP, Consultant Expert on Biosimilars, Michel Mikhail
13.30 - 17.30
Speakers
- Bernd Liedert, Senior Clinical Program Leader Biosimilars, Boehringer Ingelheim
- Chris Teale, Vice President Europe, GfK HealthCare
- Dominic Adair, Partner, Bristows LLC
- Glenn Kazo, President, Prolong Pharmaceuticals
- Harish Pai, Principal Scientific Manager, Biocon
- Harish Shandilya, Head, Global Product Development and Regulatory Affairs, Enzene Biosciences
- HoUng Kim, Division Head Strategy and Operations, Celltrion Healthcare
- Ildiko Aradi, Head, Clinical Development of Biologics, Gedeon Richter
- Matthew Turner, Global Medical Director Biosimilars, Merck Group
- Michel Mikhail, Independant Consultant, Senior VP, Consultant Expert on Biosimilars, Independant Consultant
- Richard Peck, Vice President Regulatory Affairs, Lupin (Europe)
- Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals
- Rodeina Challand, Director, Challand Biosimilar Consulting
- Sarah Rickwood, Vice President, Head of European of Thought Leadership , QuintilesIMS
- Steinar Madsen, Medical Director, Norwegian Medicines Agency
- Stephen Murby, International Advisory Board Member, Alliance for Safe Biologic Medicines
- Thomas Sachnik, Sr Manager Strategic Associate to the President & CEO Generics Europe, Teva Pharma BV
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
Holiday Inn Kensington Forum
97 Cromwell Rd, Kensington, SW7 4DN
London, UK
Who should attend
Job titles include:
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, from the following roles:
- Biopharmaceuticals/ Biotherapeutics
- Follow on Biologics/Follow on Proteins/Biosimilars
- Biologics/Biotechnology/ Biogenerics
- Legal and Regulatory Affairs
- Intellectual Property
- Pricing and Reimbursement
- Clinical operations
- Regulatory Compliance
- Pharmacovigilance
- Drug Safety & Risk Management
- Quality Affairs/ Quality Control
- Drug Development
- Research & Development
- Portfolio Management
- Business Development
- Commercial Affairs and Strategic Planning
Venue
Holiday Inn Kensington Forum97 Cromwell Road
London, United Kingdom
